Home
Conditions
Lymphoma, Mantle-Cell

Clinical trial condition

Lymphoma, Mantle-Cell

Explore clinical trials studying Lymphoma, Mantle-Cell. Study availability and eligibility vary by location and protocol.

889 public trials 111 recruiting studies

Refine in advanced search Browse all conditions

Lymphoma, Mantle-Cell trial results

Completed

Maintenance Rituximab With mTor Inhibition After High-dose Consolidative Therapy in Lymphoma

NCT01665768

Conditions: CD20+, B-cell Lymphomas, Gray Zone Lymphoma, Hemic and Lymphatic Diseases, +15 more
Locations: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins Baltimore, Maryland, United States

View Trial Details

Completed

Bortezomib, Rituximab, and Dexamethasone With or Without Temsirolimus in Treating Patients With Untreated or Relapsed Waldenstrom Macroglobulinemia or Relapsed or Refractory Mantle Cell or Follicular Lymphoma

NCT01381692

Conditions: Blood Protein Disorders, Cardiovascular Diseases, Chronic Disease, +38 more
Locations: Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States

Emory University Hospital/Winship Cancer Institute Atlanta, Georgia, United States

Mayo Clinic in Rochester Rochester, Minnesota, United States

Hackensack University Medical Center Hackensack, New Jersey, United States

View Trial Details

Completed

Zevalin Post-marketing Surveillance in Japan

NCT01448928

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations: Multiple Locations, Japan

View Trial Details

Completed

Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma

NCT00299182

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +7 more
Locations: UT MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Pemetrexed Disodium in the Cerebrospinal Fluid of Patients With Leptomeningeal Metastases

NCT00424242

Conditions: Amyloidosis, Blast Crisis, Blood Coagulation Disorders, +112 more
Locations: Robert H. Lurie Comprehensive Cancer Center at Northwestern University Chicago, Illinois, United States

View Trial Details

Completed

10-Propargyl-10-Deazaaminopterin in Treating Patients With Recurrent or Refractory Non-Hodgkin's Lymphoma or Hodgkin's Lymphoma

NCT00052442

Conditions: Burkitt Lymphoma, DNA Virus Infections, Epstein-Barr Virus Infections, +23 more
Locations: Memorial Sloan-Kettering Cancer Center New York, United States

View Trial Details

Completed

Safety Study of Different Doses of hA20 (Veltuzumab) in CD20+ Non-Hodgkin's Lymphoma

NCT00596804

Conditions: Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +14 more
Locations: Service Des Maladies Du Sang Lille, Cedex, France

Centre hospitalier Lyon Lyon, Pierre Benite Cedex, France

University of Leicester Leicester, United Kingdom

View Trial Details

Completed

Combination Chemotherapy and Donor Stem Cell Transplant in Treating Patients With Aplastic Anemia or Hematologic Cancer

NCT00003816

Conditions: Anemia, Anemia, Aplastic, Anemia, Refractory, +90 more
Locations: Roswell Park Cancer Institute Buffalo, New York, United States

View Trial Details

Completed

A Study of ABT-263 in Subjects With Relapsed or Refractory Lymphoid Malignancies

NCT00406809

Conditions: Chronic Lymphoid Leukemia, Follicular Lymphoma, Hematologic Diseases, +25 more
Locations: Site Reference ID/Investigator# 4997 Los Angeles, California, United States

Site Reference ID/Investigator# 9104 Los Angeles, California, United States

Site Reference ID/Investigator# 2613 Bethesda, Maryland, United States

Site Reference ID/Investigator# 40243 Boston, Massachusetts, United States

View Trial Details

Completed

Pembrolizumab in Patients Failing to Respond to or Relapsing After CAR T Cell Therapy for Relapsed or Refractory Lymphomas

NCT02650999

Conditions: CD19+ Diffuse Large B-cell Lymphomas, Follicular Lymphomas, Hemic and Lymphatic Diseases, +11 more
Locations: Abramson Cancer Center of the University of Pennsylvania Philadelphia, Pennsylvania, United States

View Trial Details

Lymphoma, Mantle-Cell

Lymphoma, Mantle-Cell trial results

Related conditions